Hypoglossal nerve stimulation (HGNS) therapy was approved in 2014 for the treatment of obstructive sleep apnea in patients who are intolerant to continuous positive airway pressure (CPAP) therapy, which is reported in up to 40–60% of patients. This therapy works via direct neurostimulation of the hypoglossal nerve in synchrony with respiration, to open the airway via tongue stiffening and protrusion. Studies have demonstrated significant reductions in both respiratory parameters such as disordered breathing indices, as well as subjective sleep complaints, such as daytime sleepiness, with the use of this therapy. This has increased the repertoire of treatment options for sleep providers to recommend to those patients that are intolerant to CPAP therapy.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Somers VK, White DP, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol, 52(8), 686-717 (2008).
Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep, 31(8), 1079-1085 (2008).
Marshall NS, Wong KK, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 10(4), 355-362 (2014).
Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. American journal of respiratory and critical care medicine, 165(9), 1217-1239 (2002).
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol, 177(9), 1006-1014 (2013).
Skatrud JB, Dempsey JA, Badr S, Begle RL. Effect of airway impedance on CO2 retention and respiratory muscle activity during NREM sleep. Journal of applied physiology (Bethesda, Md. : 1985), 65(4), 1676-1685 (1988).
Qaseem A, Holty JE, Owens DK et al. Management of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians. Ann Intern Med, 159(7), 471-483 (2013).
Randerath WJ, Verbraecken J, Andreas S et al. Non-CPAP therapies in obstructive sleep apnoea. The European respiratory journal, 37(5), 1000-1028 (2011).
Issa FG, Sullivan CE. Alcohol, snoring and sleep apnea. J Neurol Neurosurg Psychiatry, 45(4), 353-359 (1982).
van Maanen JP, de Vries N. Long-term effectiveness and compliance of positional therapy with the sleep position trainer in the treatment of positional obstructive sleep apnea syndrome. Sleep, 37(7), 1209-1215 (2014).
Eijsvogel MM, Ubbink R, Dekker J et al. Sleep position trainer versus tennis ball technique in positional obstructive sleep apnea syndrome. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 11(2), 139-147 (2015).
Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet, 383(9918), 736-747 (2014).
Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev, (3), CD001106 (2006).
McDaid C, Duree KH, Griffin SC et al. A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep medicine reviews, 13(6), 427-436 (2009).
Iftikhar IH, Bittencourt L, Youngstedt SD et al. Comparative efficacy of CPAP, MADs, exercise-training, and dietary weight loss for sleep apnea: a network meta-analysis. Sleep Med, 30, 7-14 (2017).
Eisele DW, Smith PL, Alam DS, Schwartz AR. Direct hypoglossal nerve stimulation in obstructive sleep apnea. Archives of otolaryngology--head & neck surgery, 123(1), 57-61 (1997).
Hida W, Kurosawa H, Okabe S et al. Hypoglossal nerve stimulation affects the pressure-volume behavior of the upper airway. American journal of respiratory and critical care medicine, 151(2 Pt 1), 455-460 (1995).
Oliven A, O'Hearn DJ, Boudewyns A et al. Upper airway response to electrical stimulation of the genioglossus in obstructive sleep apnea. Journal of applied physiology (Bethesda, Md. : 1985), 95(5), 2023-2029 (2003).
Strollo PJ, Jr., Soose RJ, Maurer JT et al. Upper-airway stimulation for obstructive sleep apnea. The New England journal of medicine, 370(2), 139-149 (2014).
Woodson BT, Strohl KP, Soose RJ et al. Upper Airway Stimulation for Obstructive Sleep Apnea: 5-Year Outcomes. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 159(1), 194-202 (2018).
Certal VF, Zaghi S, Riaz M et al. Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea: A systematic review and meta-analysis. The Laryngoscope, 125(5), 1254-1264 (2015).
Heiser C, Maurer JT, Hofauer B, Sommer JU, Seitz A, Steffen A. Outcomes of Upper Airway Stimulation for Obstructive Sleep Apnea in a Multicenter German Postmarket Study. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 156(2), 378-384 (2017).
Thaler E, Schwab R, Maurer J et al. Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy. The Laryngoscope, 130(5), 1333-1338 (2020).
Caloway CL, Diercks GR, Keamy D et al. Update on hypoglossal nerve stimulation in children with down syndrome and obstructive sleep apnea. The Laryngoscope, 130(4), E263-e267 (2020).
Sarber KM, Chang KW, Ishman SL, Epperson MV, Dhanda Patil R. Hypoglossal Nerve Stimulator Outcomes for Patients Outside the U.S. FDA Recommendations. The Laryngoscope, 130(4), 866-872 (2020).
Deep NL, Hines JP, Parish JM, Hinni ML, Bansberg SF. Subpectoral implantation of the hypoglossal nerve stimulator: An effective technical modification. The Laryngoscope, 129(10), 2420-2423 (2019).
Kumar AT, Vasconcellos A, Boon M, Huntley C. Inclusion of the first cervical nerve does not influence outcomes in upper airway stimulation for treatment of obstructive sleep apnea. The Laryngoscope, 130(5), E382-e385 (2020).
Withrow K, Evans S, Harwick J, Kezirian E, Strollo P. Upper Airway Stimulation Response in Older Adults with Moderate to Severe Obstructive Sleep Apnea. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 161(4), 714-719 (2019).
Vasconcellos AP, Huntley CT, Schell AE, Soose RJ, Boon MS. Dysfunctional hypoglossal nerve stimulator after electrical cardioversion: A case series. The Laryngoscope, 129(8), 1949-1953 (2019).
Arteaga AA, Pitts KD, Lewis AF. Iatrogenic pneumothorax during hypoglossal nerve stimulator implantation. American journal of otolaryngology, 39(5), 636-638 (2018).
Eastwood PR, Barnes M, MacKay SG et al. Bilateral hypoglossal nerve stimulation for treatment of adult obstructive sleep apnoea. The European respiratory journal, 55(1) (2020).
Kent DT, Zealear D, Schwartz AR. Ansa Cervicalis Stimulation: A New Direction in Neurostimulation for Obstructive Sleep Apnea. Chest, (2020).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Olson, M.D., Junna, M.R. Hypoglossal Nerve Stimulation Therapy for the Treatment of Obstructive Sleep Apnea. Neurotherapeutics (2021). https://doi.org/10.1007/s13311-021-01012-x
- Hypoglossal nerve stimulation therapy
- upper airway stimulation
- obstructive sleep apnea
- continuous positive airway pressure
- continue positive airway pressure intolerance